Primary Record
nalmefene
- In stock
- 7,397 g
- Purity
- 98.8 %
- CAS
- 55096-26-9
Compound Identifiers & Properties
- CAS
- 55096-26-9
- PubChem CID
- 5284594
- SMILES
- C=C1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O
- Canonical SMILES
- C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
Names & Synonyms
- nalmefene
- Nalmetrene
- Nalmefeno
- Nalmefenum
- Selincro
- Revex
- Nalmetrenum
- Nalmetreno
- Alcofene
- Incystene
- Arthene
- Cervene
- Soberal
- Cessal
- Nalmefene - d3
- JF-1
- Nalmefene HCl
- Nalmefenum [INN-Latin]
- 55096-26-9
- Nalmefeno [INN-Spanish]
- Nalmetrenum [INN-Latin]
- Nalmetreno [INN-Spanish]
- Selincro (TN)
- ORF-11676
- (-)-Nalmefene
- Nalmefene hydrochloride
- 6-Desoxy-6-methylenenaltrexone
- TOV02TDP9I
- Revex (TN)
- JF 1
- ORF 11676
- Nalmefene (USAN/INN)
- UNII-TOV02TDP9I
- CHEMBL982
- NALMEFENE [INN]
- Nalmefene [USAN:BAN:INN]
- Opera_ID_468
- RefChem:57225
- NALMEFENE [MI]
- NALMEFENE [HSDB]
- NALMEFENE [USAN]
- NALMEFENE [VANDF]
- SRD174
- DTXSID8023347
- Nalmefene [USAN:INN:BAN]
- D05VIL
- NALMEFENE [MART.]
- HSDB 6761
- JKB-121
- MLS000069366
- NALMEFENE [WHO-DD]
- SRD-174
- DTXCID903347
- SCHEMBL35230
- ORF 1167
- ORF-1167
- 6-Deoxo-6-methylenenaltrexone
- Nalmefene hydrochloride hydrate
- CHEBI:7457
- GTPL1628
- orb2565730
- Revex (nalmefene hydrochloride)
- Nalmefene hydrochloride dihydrate
- SCHEMBL29373615
- C21H25NO3
- cid_5284594
- NIH-10365
- WJBLNOPPDWQMCH-MBPVOVBZSA-N
- HMS2232D07
- ZINC403529
- BCP16723
- Tox21_110873
- BDBM50045776
- C21-H25-N-O3
- EBC-26651
- MSK159678
- NCGC00021666-03
- PDSP2_001543
- SMR000058884
- Tox21_110873_1
- BN36715
- CID5284594
- DB06230
- NCGC00021666-04
- AN-40433
- DA-65915
- J23.288B
- LS-91713
- 17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol
- CAS-55096-26-9
- HY-107744
- Opvee (nalmefene hydrochloride nasal spray)
- B5505
- CS-0029442
- NS00068285
- (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol
- C08027
- D05111
- 9a-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylen-3,14-morphinandiol
- AB00384250_10
- 096N269
- EN300-18384909
- Q4353252
- (5alpha)-17-(cyclopropylmethyl)-6-methylidene-4,5-epoxymorphinan-3,14-diol
- Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5alpha)-
- (4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
- (4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol
- (5-alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
- (5|A)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
- (5a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol;
- (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol
- 17-(Cyclopropylmethyl)-6-methylidene-5alpha-4,5-epoxymorphinan-3,14-diol
- 4,5alpha-Epoxy-6-methylene-17-(cyclopropylmethyl)morphinan-3,14-diol
- Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5.alpha.)-
- (1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7,9,11(18)-triene-10,17-diol
- (1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol
- (1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,17-diol
- (1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-triene-10,17-diol
- 1228646-70-5